Clinical Trial Update: Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

View source ↗

Summary

An ongoing clinical study is investigating therapeutic resistance and clonal evolution in non-small cell lung cancer patients treated with immune checkpoint inh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Snippet

Sponsor: Geneplus-Beijing Co. Ltd. | Conditions: Lung Neoplasms, Lung Cancer, Nonsmall Cell | Status: RECRUITING